+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Extracorporeal Membrane Oxygenation Market: Global Opportunity Analysis and Industry Forecast, 2024-2035

  • PDF Icon

    Report

  • 403 Pages
  • March 2025
  • Region: Global
  • Allied Market Research
  • ID: 6120004
Description Jump to:
Extracorporeal membrane oxygenation (ECMO) is a type of life support used when a person's heart and lungs are not working properly. ECMO takes blood out of body, sends it through devices to add oxygen and remove carbondioxide, and then pumps the blood back into body. This process provides temporary support, allowing the heart and lungs to rest and recover. ECMO is commonly used in critical care settings for conditions such as severe pneumonia, acute respiratory distress syndrome (ARDS), and cardiac arrest. It is typically categorized into two types, such as veno-arterial (VA) ECMO, which supports both heart and lung function, and veno-venous (VV) ECMO, which primarily supports lung function. While ECMO can be lifesaving, it is a complex procedure that requires continuous monitoring and is associated with potential risks, including bleeding, infection, and complications related to blood clotting.

The extracorporeal membrane oxygenation (ECMO) market is driven by rise in prevalence of respiratory and cardiac failures, fueled by conditions such as chronic obstructive pulmonary disease (COPD), acute respiratory distress syndrome (ARDS), and heart failure. The increase in prevalence of respiratory diseases, particularly among aging population and critically ill patients, is boosting demand for ECMO systems as a life-saving intervention. In addition, rise in government initiatives and funding aimed at improving critical care infrastructure is also driving the market growth. Many countries are expanding ECMO programs in hospitals, increasing access to extracorporeal life support. Furthermore, rise in awareness among healthcare professionals about the advantages of ECMO in managing severe respiratory and cardiac conditions is leading to a greater adoption of the ECMO solutions. As more healthcare providers recognize its potential in saving lives and improving patient outcomes, the demand for ECMO systems continues to rise, thereby contributing to the growth of the market.

However, high costs associated with ECMO systems, including equipment, maintenance, and operational expenses, make it less accessible, particularly in developing regions, thereby restricting the market growth. The procedure requires highly trained healthcare professionals, and a shortage of skilled personnel limits its widespread adoption. On the other hand, innovations in portable and user-friendly ECMO systems are enhancing accessibility and efficiency, making them more viable for use in emergency and transport settings which provides an opportunity for the market growth.

The extracorporeal membrane oxygenation market is segmented into component, modulation, application, patient type, and region. By component, the market is segregated into controllers, pumps, oxygenator, cannula, and accessories. By modulation, the market is categorized into veno arterial (VA), veno venous (VV), and others. By application, the market is classified into cardiac diseases, respiratory disorders, and extracorporeal cardiopulmonary resuscitation. By patient type, the market is classified into neonates, pediatric, and adult. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, Russia, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, Thailand, Malaysia, Indonesia, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, UAE, Argentina, and Rest of LAMEA).

Major players that operate in the extracorporeal membrane oxygenation market are Medtronic plc, Terumo Corporation, Fresenius SE & Co. KGaA, Getinge, Microport Scientific Corporation, LivaNova, Inc., EUROSETS, CytoSorbents Corporation, Abbott Laboratories, and Chalice Medical Ltd. Key players have adopted product launch, agreement, collaboration, expansion, and product approval as key developmental strategies to improve the product portfolio of the extracorporeal membrane oxygenation market.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the extracorporeal membrane oxygenation market analysis from 2023 to 2035 to identify the prevailing extracorporeal membrane oxygenation market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the extracorporeal membrane oxygenation market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global extracorporeal membrane oxygenation market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Modulation

  • Others
  • Veno arterial
  • Veno venous

By Application

  • Cardiac Diseases
  • Respiratory Disorders
  • Extracorporeal Cardiopulmonary Resuscitation

By Patient Type

  • Neonates
  • Pediatric
  • Adult

By Component

  • Controllers
  • Pumps
  • Oxygenator
  • Cannula
  • Accessories

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • UAE
  • Argentina
  • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • Terumo Corporation
  • Eurosets
  • Getinge
  • Chalice Medical Ltd.
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • CytoSorbents Corporation
  • Fresenius SE & Co. KGaA
  • Abbott Laboratories

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Growing prevalence of respiratory and cardiac diseases
3.4.1.2. Government initiatives and healthcare funding
3.4.1.3. Increasing adoption of ECMO in pediatric and neonatal care
3.4.2. Restraints
3.4.2.1. High cost of ECMO systems and procedures
3.4.3. Opportunities
3.4.3.1. High growth potential in emerging countries
3.4.3.2. Technological advancements in ECMO systems
CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Controllers
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Pumps
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Oxygenator
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Cannula
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
4.6. Accessories
4.6.1. Key market trends, growth factors and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market share analysis by country
CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODULATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Veno arterial
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Veno venous
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Cardiac Diseases
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Respiratory Disorders
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Extracorporeal Cardiopulmonary Resuscitation
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE
7.1. Overview
7.1.1. Market size and forecast
7.2. Neonates
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by region
7.2.3. Market share analysis by country
7.3. Pediatric
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by region
7.3.3. Market share analysis by country
7.4. Adult
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by region
7.4.3. Market share analysis by country
CHAPTER 8: EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION
8.1. Overview
8.1.1. Market size and forecast By Region
8.2. North America
8.2.1. Key market trends, growth factors and opportunities
8.2.2. Market size and forecast, by Component
8.2.3. Market size and forecast, by Modulation
8.2.4. Market size and forecast, by Application
8.2.5. Market size and forecast, by Patient Type
8.2.6. Market size and forecast, by country
8.2.6.1. U.S.
8.2.6.1.1. Market size and forecast, by Component
8.2.6.1.2. Market size and forecast, by Modulation
8.2.6.1.3. Market size and forecast, by Application
8.2.6.1.4. Market size and forecast, by Patient Type
8.2.6.2. Canada
8.2.6.2.1. Market size and forecast, by Component
8.2.6.2.2. Market size and forecast, by Modulation
8.2.6.2.3. Market size and forecast, by Application
8.2.6.2.4. Market size and forecast, by Patient Type
8.2.6.3. Mexico
8.2.6.3.1. Market size and forecast, by Component
8.2.6.3.2. Market size and forecast, by Modulation
8.2.6.3.3. Market size and forecast, by Application
8.2.6.3.4. Market size and forecast, by Patient Type
8.3. Europe
8.3.1. Key market trends, growth factors and opportunities
8.3.2. Market size and forecast, by Component
8.3.3. Market size and forecast, by Modulation
8.3.4. Market size and forecast, by Application
8.3.5. Market size and forecast, by Patient Type
8.3.6. Market size and forecast, by country
8.3.6.1. Germany
8.3.6.1.1. Market size and forecast, by Component
8.3.6.1.2. Market size and forecast, by Modulation
8.3.6.1.3. Market size and forecast, by Application
8.3.6.1.4. Market size and forecast, by Patient Type
8.3.6.2. France
8.3.6.2.1. Market size and forecast, by Component
8.3.6.2.2. Market size and forecast, by Modulation
8.3.6.2.3. Market size and forecast, by Application
8.3.6.2.4. Market size and forecast, by Patient Type
8.3.6.3. UK
8.3.6.3.1. Market size and forecast, by Component
8.3.6.3.2. Market size and forecast, by Modulation
8.3.6.3.3. Market size and forecast, by Application
8.3.6.3.4. Market size and forecast, by Patient Type
8.3.6.4. Italy
8.3.6.4.1. Market size and forecast, by Component
8.3.6.4.2. Market size and forecast, by Modulation
8.3.6.4.3. Market size and forecast, by Application
8.3.6.4.4. Market size and forecast, by Patient Type
8.3.6.5. Spain
8.3.6.5.1. Market size and forecast, by Component
8.3.6.5.2. Market size and forecast, by Modulation
8.3.6.5.3. Market size and forecast, by Application
8.3.6.5.4. Market size and forecast, by Patient Type
8.3.6.6. Russia
8.3.6.6.1. Market size and forecast, by Component
8.3.6.6.2. Market size and forecast, by Modulation
8.3.6.6.3. Market size and forecast, by Application
8.3.6.6.4. Market size and forecast, by Patient Type
8.3.6.7. Rest of Europe
8.3.6.7.1. Market size and forecast, by Component
8.3.6.7.2. Market size and forecast, by Modulation
8.3.6.7.3. Market size and forecast, by Application
8.3.6.7.4. Market size and forecast, by Patient Type
8.4. Asia-Pacific
8.4.1. Key market trends, growth factors and opportunities
8.4.2. Market size and forecast, by Component
8.4.3. Market size and forecast, by Modulation
8.4.4. Market size and forecast, by Application
8.4.5. Market size and forecast, by Patient Type
8.4.6. Market size and forecast, by country
8.4.6.1. Japan
8.4.6.1.1. Market size and forecast, by Component
8.4.6.1.2. Market size and forecast, by Modulation
8.4.6.1.3. Market size and forecast, by Application
8.4.6.1.4. Market size and forecast, by Patient Type
8.4.6.2. China
8.4.6.2.1. Market size and forecast, by Component
8.4.6.2.2. Market size and forecast, by Modulation
8.4.6.2.3. Market size and forecast, by Application
8.4.6.2.4. Market size and forecast, by Patient Type
8.4.6.3. India
8.4.6.3.1. Market size and forecast, by Component
8.4.6.3.2. Market size and forecast, by Modulation
8.4.6.3.3. Market size and forecast, by Application
8.4.6.3.4. Market size and forecast, by Patient Type
8.4.6.4. Australia
8.4.6.4.1. Market size and forecast, by Component
8.4.6.4.2. Market size and forecast, by Modulation
8.4.6.4.3. Market size and forecast, by Application
8.4.6.4.4. Market size and forecast, by Patient Type
8.4.6.5. South Korea
8.4.6.5.1. Market size and forecast, by Component
8.4.6.5.2. Market size and forecast, by Modulation
8.4.6.5.3. Market size and forecast, by Application
8.4.6.5.4. Market size and forecast, by Patient Type
8.4.6.6. Thailand
8.4.6.6.1. Market size and forecast, by Component
8.4.6.6.2. Market size and forecast, by Modulation
8.4.6.6.3. Market size and forecast, by Application
8.4.6.6.4. Market size and forecast, by Patient Type
8.4.6.7. Malaysia
8.4.6.7.1. Market size and forecast, by Component
8.4.6.7.2. Market size and forecast, by Modulation
8.4.6.7.3. Market size and forecast, by Application
8.4.6.7.4. Market size and forecast, by Patient Type
8.4.6.8. Indonesia
8.4.6.8.1. Market size and forecast, by Component
8.4.6.8.2. Market size and forecast, by Modulation
8.4.6.8.3. Market size and forecast, by Application
8.4.6.8.4. Market size and forecast, by Patient Type
8.4.6.9. Rest of Asia-Pacific
8.4.6.9.1. Market size and forecast, by Component
8.4.6.9.2. Market size and forecast, by Modulation
8.4.6.9.3. Market size and forecast, by Application
8.4.6.9.4. Market size and forecast, by Patient Type
8.5. LAMEA
8.5.1. Key market trends, growth factors and opportunities
8.5.2. Market size and forecast, by Component
8.5.3. Market size and forecast, by Modulation
8.5.4. Market size and forecast, by Application
8.5.5. Market size and forecast, by Patient Type
8.5.6. Market size and forecast, by country
8.5.6.1. Brazil
8.5.6.1.1. Market size and forecast, by Component
8.5.6.1.2. Market size and forecast, by Modulation
8.5.6.1.3. Market size and forecast, by Application
8.5.6.1.4. Market size and forecast, by Patient Type
8.5.6.2. Saudi Arabia
8.5.6.2.1. Market size and forecast, by Component
8.5.6.2.2. Market size and forecast, by Modulation
8.5.6.2.3. Market size and forecast, by Application
8.5.6.2.4. Market size and forecast, by Patient Type
8.5.6.3. South Africa
8.5.6.3.1. Market size and forecast, by Component
8.5.6.3.2. Market size and forecast, by Modulation
8.5.6.3.3. Market size and forecast, by Application
8.5.6.3.4. Market size and forecast, by Patient Type
8.5.6.4. UAE
8.5.6.4.1. Market size and forecast, by Component
8.5.6.4.2. Market size and forecast, by Modulation
8.5.6.4.3. Market size and forecast, by Application
8.5.6.4.4. Market size and forecast, by Patient Type
8.5.6.5. Argentina
8.5.6.5.1. Market size and forecast, by Component
8.5.6.5.2. Market size and forecast, by Modulation
8.5.6.5.3. Market size and forecast, by Application
8.5.6.5.4. Market size and forecast, by Patient Type
8.5.6.6. Rest of LAMEA
8.5.6.6.1. Market size and forecast, by Component
8.5.6.6.2. Market size and forecast, by Modulation
8.5.6.6.3. Market size and forecast, by Application
8.5.6.6.4. Market size and forecast, by Patient Type
CHAPTER 9: COMPETITIVE LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product mapping of top 10 player
9.4. Competitive dashboard
9.5. Competitive heatmap
9.6. Top player positioning, 2023
CHAPTER 10: COMPANY PROFILES
10.1. Getinge
10.1.1. Company overview
10.1.2. Key executives
10.1.3. Company snapshot
10.1.4. Operating business segments
10.1.5. Product portfolio
10.1.6. Business performance
10.1.7. Key strategic moves and developments
10.2. Medtronic plc
10.2.1. Company overview
10.2.2. Key executives
10.2.3. Company snapshot
10.2.4. Operating business segments
10.2.5. Product portfolio
10.2.6. Business performance
10.2.7. Key strategic moves and developments
10.3. Terumo Corporation
10.3.1. Company overview
10.3.2. Key executives
10.3.3. Company snapshot
10.3.4. Operating business segments
10.3.5. Product portfolio
10.3.6. Business performance
10.4. MicroPort Scientific Corporation
10.4.1. Company overview
10.4.2. Key executives
10.4.3. Company snapshot
10.4.4. Operating business segments
10.4.5. Product portfolio
10.4.6. Business performance
10.5. LivaNova PLC
10.5.1. Company overview
10.5.2. Key executives
10.5.3. Company snapshot
10.5.4. Operating business segments
10.5.5. Product portfolio
10.5.6. Business performance
10.6. Eurosets
10.6.1. Company overview
10.6.2. Key executives
10.6.3. Company snapshot
10.6.4. Operating business segments
10.6.5. Product portfolio
10.7. CytoSorbents Corporation
10.7.1. Company overview
10.7.2. Key executives
10.7.3. Company snapshot
10.7.4. Operating business segments
10.7.5. Product portfolio
10.7.6. Key strategic moves and developments
10.8. Abbott Laboratories
10.8.1. Company overview
10.8.2. Key executives
10.8.3. Company snapshot
10.8.4. Operating business segments
10.8.5. Product portfolio
10.8.6. Business performance
10.8.7. Key strategic moves and developments
10.9. Fresenius SE & Co. KGaA
10.9.1. Company overview
10.9.2. Key executives
10.9.3. Company snapshot
10.9.4. Operating business segments
10.9.5. Product portfolio
10.9.6. Business performance
10.9.7. Key strategic moves and developments
10.10. Chalice Medical Ltd.
10.10.1. Company overview
10.10.2. Key executives
10.10.3. Company snapshot
10.10.4. Operating business segments
10.10.5. Product portfolio
LIST OF TABLES
Table 01. Global Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 02. Extracorporeal Membrane Oxygenation Market for Controllers, by Region, 2023-2035 ($Million)
Table 03. Extracorporeal Membrane Oxygenation Market for Pumps, by Region, 2023-2035 ($Million)
Table 04. Extracorporeal Membrane Oxygenation Market for Oxygenator, by Region, 2023-2035 ($Million)
Table 05. Extracorporeal Membrane Oxygenation Market for Cannula, by Region, 2023-2035 ($Million)
Table 06. Extracorporeal Membrane Oxygenation Market for Accessories, by Region, 2023-2035 ($Million)
Table 07. Global Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 08. Extracorporeal Membrane Oxygenation Market for Veno Arterial, by Region, 2023-2035 ($Million)
Table 09. Extracorporeal Membrane Oxygenation Market for Veno Venous, by Region, 2023-2035 ($Million)
Table 10. Extracorporeal Membrane Oxygenation Market for Others, by Region, 2023-2035 ($Million)
Table 11. Global Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 12. Extracorporeal Membrane Oxygenation Market for Cardiac Diseases, by Region, 2023-2035 ($Million)
Table 13. Extracorporeal Membrane Oxygenation Market for Respiratory Disorders, by Region, 2023-2035 ($Million)
Table 14. Extracorporeal Membrane Oxygenation Market for Extracorporeal Cardiopulmonary Resuscitation, by Region, 2023-2035 ($Million)
Table 15. Global Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 16. Extracorporeal Membrane Oxygenation Market for Neonates, by Region, 2023-2035 ($Million)
Table 17. Extracorporeal Membrane Oxygenation Market for Pediatric, by Region, 2023-2035 ($Million)
Table 18. Extracorporeal Membrane Oxygenation Market for Adult, by Region, 2023-2035 ($Million)
Table 19. Extracorporeal Membrane Oxygenation Market, by Region, 2023-2035 ($Million)
Table 20. North America Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 21. North America Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 22. North America Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 23. North America Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 24. North America Extracorporeal Membrane Oxygenation Market, by Country, 2023-2035 ($Million)
Table 25. U.S. Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 26. U.S. Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 27. U.S. Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 28. U.S. Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 29. Canada Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 30. Canada Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 31. Canada Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 32. Canada Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 33. Mexico Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 34. Mexico Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 35. Mexico Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 36. Mexico Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 37. Europe Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 38. Europe Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 39. Europe Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 40. Europe Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 41. Europe Extracorporeal Membrane Oxygenation Market, by Country, 2023-2035 ($Million)
Table 42. Germany Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 43. Germany Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 44. Germany Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 45. Germany Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 46. France Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 47. France Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 48. France Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 49. France Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 50. UK Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 51. UK Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 52. UK Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 53. UK Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 54. Italy Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 55. Italy Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 56. Italy Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 57. Italy Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 58. Spain Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 59. Spain Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 60. Spain Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 61. Spain Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 62. Russia Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 63. Russia Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 64. Russia Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 65. Russia Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 66. Rest of Europe Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 67. Rest of Europe Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 68. Rest of Europe Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 69. Rest of Europe Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 70. Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 71. Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 72. Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 73. Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 74. Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Country, 2023-2035 ($Million)
Table 75. Japan Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 76. Japan Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 77. Japan Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 78. Japan Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 79. China Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 80. China Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 81. China Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 82. China Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 83. India Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 84. India Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 85. India Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 86. India Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 87. Australia Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 88. Australia Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 89. Australia Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 90. Australia Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 91. South Korea Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 92. South Korea Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 93. South Korea Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 94. South Korea Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 95. Thailand Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 96. Thailand Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 97. Thailand Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 98. Thailand Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 99. Malaysia Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 100. Malaysia Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 101. Malaysia Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 102. Malaysia Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 103. Indonesia Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 104. Indonesia Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 105. Indonesia Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 106. Indonesia Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 107. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 108. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 109. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 110. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 111. LAMEA Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 112. LAMEA Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 113. LAMEA Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 114. LAMEA Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 115. LAMEA Extracorporeal Membrane Oxygenation Market, by Country, 2023-2035 ($Million)
Table 116. Brazil Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 117. Brazil Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 118. Brazil Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 119. Brazil Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 120. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 121. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 122. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 123. Saudi Arabia Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 124. South Africa Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 125. South Africa Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 126. South Africa Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 127. South Africa Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 128. UAE Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 129. UAE Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 130. UAE Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 131. UAE Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 132. Argentina Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 133. Argentina Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 134. Argentina Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 135. Argentina Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 136. Rest of LAMEA Extracorporeal Membrane Oxygenation Market, by Component, 2023-2035 ($Million)
Table 137. Rest of LAMEA Extracorporeal Membrane Oxygenation Market, by Modulation, 2023-2035 ($Million)
Table 138. Rest of LAMEA Extracorporeal Membrane Oxygenation Market, by Application, 2023-2035 ($Million)
Table 139. Rest of LAMEA Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023-2035 ($Million)
Table 140. Getinge: Key Executives
Table 141. Getinge: Company Snapshot
Table 142. Getinge: Product Segments
Table 143. Getinge: Product Portfolio
Table 144. Getinge: Key Stratergies
Table 145. Medtronic plc: Key Executives
Table 146. Medtronic plc: Company Snapshot
Table 147. Medtronic plc: Product Segments
Table 148. Medtronic plc: Product Portfolio
Table 149. Medtronic plc: Key Stratergies
Table 150. Terumo Corporation: Key Executives
Table 151. Terumo Corporation: Company Snapshot
Table 152. Terumo Corporation: Product Segments
Table 153. Terumo Corporation: Product Portfolio
Table 154. Microport Scientific Corporation: Key Executives
Table 155. Microport Scientific Corporation: Company Snapshot
Table 156. Microport Scientific Corporation: Product Segments
Table 157. Microport Scientific Corporation: Product Portfolio
Table 158. Livanova plc: Key Executives
Table 159. Livanova plc: Company Snapshot
Table 160. Livanova plc: Product Segments
Table 161. Livanova plc: Product Portfolio
Table 162. Eurosets: Key Executives
Table 163. Eurosets: Company Snapshot
Table 164. Eurosets: Product Segments
Table 165. Eurosets: Product Portfolio
Table 166. Cytosorbents Corporation: Key Executives
Table 167. Cytosorbents Corporation: Company Snapshot
Table 168. Cytosorbents Corporation: Product Segments
Table 169. Cytosorbents Corporation: Product Portfolio
Table 170. Cytosorbents Corporation: Key Stratergies
Table 171. Abbott Laboratories: Key Executives
Table 172. Abbott Laboratories: Company Snapshot
Table 173. Abbott Laboratories: Product Segments
Table 174. Abbott Laboratories: Product Portfolio
Table 175. Abbott Laboratories: Key Stratergies
Table 176. Fresenius Se & Co. KGaA: Key Executives
Table 177. Fresenius Se & Co. KGaA: Company Snapshot
Table 178. Fresenius Se & Co. KGaA: Product Segments
Table 179. Fresenius Se & Co. KGaA: Product Portfolio
Table 180. Fresenius Se & Co. KGaA: Key Stratergies
Table 181. Chalice Medical Ltd.: Key Executives
Table 182. Chalice Medical Ltd.: Company Snapshot
Table 183. Chalice Medical Ltd.: Product Segments
Table 184. Chalice Medical Ltd.: Product Portfolio
LIST OF FIGURES
Figure 01. Extracorporeal Membrane Oxygenation Market, 2023-2035
Figure 02. Segmentation of Extracorporeal Membrane Oxygenation Market,2023-2035
Figure 03. Top Impacting Factors in Extracorporeal Membrane Oxygenation Market (2023 to 2035)
Figure 04. Top Investment Pockets in Extracorporeal Membrane Oxygenation Market (2024-2035)
Figure 05. Moderate Bargaining Power of Suppliers
Figure 06. Moderate Threat of New Entrants
Figure 07. Moderate Threat of Substitutes
Figure 08. Moderate Intensity of Rivalry
Figure 09. Moderate Bargaining Power of Buyers
Figure 10. Global Extracorporeal Membrane Oxygenation Market:Drivers, Restraints and Opportunities
Figure 11. Extracorporeal Membrane Oxygenation Market, by Component, 2023 and 2035(%)
Figure 12. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Controllers, by Country 2023 and 2035(%)
Figure 13. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Pumps, by Country 2023 and 2035(%)
Figure 14. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Oxygenator, by Country 2023 and 2035(%)
Figure 15. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Cannula, by Country 2023 and 2035(%)
Figure 16. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Accessories, by Country 2023 and 2035(%)
Figure 17. Extracorporeal Membrane Oxygenation Market, by Modulation, 2023 and 2035(%)
Figure 18. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Veno Arterial, by Country 2023 and 2035(%)
Figure 19. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Veno Venous, by Country 2023 and 2035(%)
Figure 20. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Others, by Country 2023 and 2035(%)
Figure 21. Extracorporeal Membrane Oxygenation Market, by Application, 2023 and 2035(%)
Figure 22. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Cardiac Diseases, by Country 2023 and 2035(%)
Figure 23. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Respiratory Disorders, by Country 2023 and 2035(%)
Figure 24. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Extracorporeal Cardiopulmonary Resuscitation, by Country 2023 and 2035(%)
Figure 25. Extracorporeal Membrane Oxygenation Market, by Patient Type, 2023 and 2035(%)
Figure 26. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Neonates, by Country 2023 and 2035(%)
Figure 27. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Pediatric, by Country 2023 and 2035(%)
Figure 28. Comparative Share Analysis of Extracorporeal Membrane Oxygenation Market for Adult, by Country 2023 and 2035(%)
Figure 29. Extracorporeal Membrane Oxygenation Market by Region, 2023 and 2035(%)
Figure 30. U.S. Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 31. Canada Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 32. Mexico Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 33. Germany Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 34. France Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 35. UK Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 36. Italy Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 37. Spain Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 38. Russia Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 39. Rest of Europe Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 40. Japan Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 41. China Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 42. India Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 43. Australia Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 44. South Korea Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 45. Thailand Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 46. Malaysia Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 47. Indonesia Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 48. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 49. Brazil Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 50. Saudi Arabia Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 51. South Africa Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 52. UAE Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 53. Argentina Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 54. Rest of LAMEA Extracorporeal Membrane Oxygenation Market, 2023-2035 ($Million)
Figure 55. Top Winning Strategies, by Year (2021-2025)
Figure 56. Top Winning Strategies, by Development (2021-2025)
Figure 57. Top Winning Strategies, by Company (2021-2025)
Figure 58. Product Mapping of Top 10 Players
Figure 59. Competitive Dashboard
Figure 60. Competitive Heatmap: Extracorporeal Membrane Oxygenation Market
Figure 61. Top Player Positioning, 2023
Figure 62. Getinge: Net Revenue, 2021-2023 ($Million)
Figure 63. Getinge: Revenue Share by Segment, 2023 (%)
Figure 64. Getinge: Revenue Share by Region, 2023 (%)
Figure 65. Medtronic PLC: Net Sales, 2022-2024 ($Million)
Figure 66. Medtronic PLC: Revenue Share by Segment, 2024 (%)
Figure 67. Medtronic PLC: Revenue Share by Region, 2024 (%)
Figure 68. Terumo Corporation: Net Revenue, 2022-2024 ($Million)
Figure 69. Terumo Corporation: Revenue Share by Segment, 2024 (%)
Figure 70. Terumo Corporation: Revenue Share by Region, 2024 (%)
Figure 71. Microport Scientific Corporation: Net Revenue, 2021-2023 ($Million)
Figure 72. Microport Scientific Corporation: Revenue Share by Segment, 2023 (%)
Figure 73. Microport Scientific Corporation: Revenue Share by Region, 2023 (%)
Figure 74. Livanova PLC: Net Revenue, 2021-2023 ($Million)
Figure 75. Livanova PLC: Revenue Share by Segment, 2023 (%)
Figure 76. Livanova PLC: Revenue Share by Region, 2023 (%)
Figure 77. Abbott Laboratories: Net Sales, 2022-2024 ($Million)
Figure 78. Abbott Laboratories: Revenue Share by Segment, 2024 (%)
Figure 79. Abbott Laboratories: Revenue Share by Region, 2024 (%)
Figure 80. Fresenius SE & Co. KGaA: Net Revenue, 2021-2023 ($Million)
Figure 81. Fresenius SE & Co. KGaA: Revenue Share by Segment, 2023 (%)
Figure 82. Fresenius SE & Co. KGaA: Revenue Share by Region, 2023 (%)

Companies Mentioned

  • Medtronic plc
  • Terumo Corporation
  • Eurosets
  • Getinge
  • Chalice Medical Ltd.
  • MicroPort Scientific Corporation
  • LivaNova PLC
  • CytoSorbents Corporation
  • Fresenius SE & Co. KGaA
  • Abbott Laboratories

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Related Topics

Related Reports

Extracorporeal Membrane Oxygenation Market By Product Type, By Application, By Modality, By Patient Type, and By End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035 - Product Image

Extracorporeal Membrane Oxygenation Market By Product Type, By Application, By Modality, By Patient Type, and By End-User, Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

  • Report
  • 220 Pages
  • Global
From
Extracorporeal Membrane Oxygenation Machine Market by Device Type (Veno Arterial, Veno Venous), Application (Cardiac Support, Extracorporeal Cardiopulmonary Resuscitation, Respiratory Support), End User, Technology Type - Global Forecast 2025-2030 - Product Image

Extracorporeal Membrane Oxygenation Machine Market by Device Type (Veno Arterial, Veno Venous), Application (Cardiac Support, Extracorporeal Cardiopulmonary Resuscitation, Respiratory Support), End User, Technology Type - Global Forecast 2025-2030

  • Report
  • 190 Pages
  • Global
From
Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report 2025 - Product Image

Extracorporeal Membrane Oxygenation Machine (ECMO) Machine Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation (ECMO) Machine - Global Strategic Business Report

  • Report
  • 294 Pages
  • Global
From
Extracorporeal Membrane Oxygenation Cannula - Global Strategic Business Report - Product Image

Extracorporeal Membrane Oxygenation Cannula - Global Strategic Business Report

  • Report
  • 463 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.